Source comparison
Melanotan-2 Research Log Track Document: Field Comparison
Dosage "Administered 0.25mg MT-2" 250 mcg reconstituted from 10mg vial at 1mg/mL, confirmed via peptide mass calculation Concentration errors are the #1 cause of underdosing or overdosing in peptide research Timing "Morning injection" 08:47 timestamp, 89 minut
This comparison does not assign a generated winner or score.
- Dosage
- "Administered 0.25mg MT-2"
- 250 mcg reconstituted from 10mg vial at 1mg/mL, confirmed via peptide mass calculation
- Concentration errors are the #1 cause of underdosing or overdosing in peptide research
- Timing
- "Morning injection"
- 08:47 timestamp, 89 minutes post-reconstitution, vial stored at 4°C since prior dose
- Peptide degradation accelerates above 8°C; timing precision required for PK correlation
- Pigmentation
- "Skin looks darker"
- Fitzpatrick Type II → Type III progression, spectrophotometry reading 42.3 melanin units
- Subjective descriptions cannot be compared across protocols or replicated
- Nausea
- "Felt nauseous"
- VAS 7/10 at 68 minutes post-injection, resolved to VAS 2/10 by 4 hours
- Severity and timeline reveal dose-response relationship and tolerance development
- Professional Assessment
- No structured data capture; observations are anecdotal and cannot be analysed statistically
- All adverse events, receptor-mediated responses, and pigmentation changes are quantified using validated scales, enabling dose-response curve generation and threshold identification
- Only structured, quantitative logging produces datasets that meet reproducibility standards for peptide research